Fraser Callum G
Centre for Research into Cancer Prevention and Screening, University of Dundee, Ninewells Hospital and Medical School, Dundee, DD1 9SY, Scotland, UK.
BMC Med. 2016 Sep 26;14(1):139. doi: 10.1186/s12916-016-0694-3.
Bowel endoscopy referrals from primary care have increased steadily over recent years. However, most patients do not have significant colorectal disease (SCD). Therefore, strategies to select those who would benefit most from endoscopy are of current interest. A recent study developed a multivariable diagnostic model for SCD with routine clinical information, extended with quantitative faecal calprotectin (f-C) point-of-care (POC) testing and/or qualitative POC faecal immunochemical test (FIT) for haemoglobin (f-Hb) results. This study used POC tests for both f-C and f-Hb; however, POC tests have many disadvantages and there are several reasons why quantitative measurements of f-Hb are advantageous. Quantitative faecal immunochemical tests have been used very successfully in triage of patients presenting in primary care as a rule-out test. Studies have compared f-C and f-Hb in this clinical context and consider that f-C is not required in diagnosis. A single quantitative f-Hb result, without any clinical information, could be sufficient to decide whom to refer for endoscopy and, because of the significant overlap of symptoms in those with and without SCD, could be the primary investigation performed.Please see related article: http://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0684-5 .
近年来,基层医疗转诊的肠道内窥镜检查数量稳步增加。然而,大多数患者并无严重的结直肠疾病(SCD)。因此,选择那些能从内窥镜检查中获益最大的患者的策略成为了当前关注的焦点。最近一项研究利用常规临床信息开发了一种用于SCD的多变量诊断模型,并通过定量粪便钙卫蛋白(f-C)即时检测(POC)和/或定性POC粪便免疫化学检测血红蛋白(f-Hb)结果进行扩展。该研究对f-C和f-Hb均采用了POC检测;然而,POC检测存在诸多缺点,且定量测量f-Hb具有多个优势。定量粪便免疫化学检测作为一种排除检测,在基层医疗中对患者进行分流时已得到非常成功的应用。已有研究在这一临床背景下比较了f-C和f-Hb,并认为诊断时无需f-C。仅凭单一的定量f-Hb结果,无需任何临床信息,就足以决定将哪些患者转诊进行内窥镜检查,而且由于有SCD和无SCD患者的症状存在显著重叠,这可能是首要进行的检查。请参阅相关文章:http://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0684-5 。